Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 73,795 | 50,790 | 55,596 | 69,514 | 60,249 |
| Cost of Goods | 11,985 | 10,966 | 8,689 | 13,229 | 13,537 |
| Gross Profit | 61,810 | 39,824 | 46,907 | 56,285 | 46,712 |
| Operating Expenses | 57,597 | 58,559 | 56,087 | 51,398 | 50,654 |
| Operating Income | 5,198 | -17,769 | -8,491 | 5,116 | -3,405 |
| Interest Expense | 1,698 | 1,695 | 1,692 | 1,691 | 1,688 |
| Other Income | 11,406 | 7,967 | 11,179 | 10,721 | 9,300 |
| Pre-tax Income | 14,906 | -11,497 | 996 | 14,146 | 4,207 |
| Income Tax | 3,520 | -2,776 | 777 | -147 | 776 |
| Net Income Continuous | 11,386 | -8,721 | 219 | 14,293 | 3,431 |
| Net Income | $11,386 | $-8,721 | $219 | $14,293 | $3,431 |
| EPS Basic Total Ops | 0.09 | -0.07 | N/A | 0.11 | 0.03 |
| EPS Basic Continuous Ops | 0.09 | -0.07 | 0.00 | 0.11 | 0.03 |
| EPS Diluted Total Ops | 0.08 | -0.07 | 0.01 | 0.10 | 0.03 |
| EPS Diluted Continuous Ops | 0.07 | -0.07 | 0.03 | 0.09 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.08 | -0.07 | 0.00 | N/A | N/A |
| EBITDA(a) | $3,240 | $-20,349 | $-11,775 | $2,936 | $-5,377 |